389 related articles for article (PubMed ID: 19251976)
1. Novel mutations in patients with McArdle disease by analysis of skeletal muscle mRNA.
García-Consuegra I; Rubio JC; Nogales-Gadea G; Bautista J; Jiménez S; Cabello A; Lucía A; Andreu AL; Arenas J; Martin MA
J Med Genet; 2009 Mar; 46(3):198-202. PubMed ID: 19251976
[TBL] [Abstract][Full Text] [Related]
2. A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients.
Rubio JC; Garcia-Consuegra I; Nogales-Gadea G; Blazquez A; Cabello A; Lucia A; Andreu AL; Arenas J; Martin MA
Hum Mutat; 2007 Feb; 28(2):203-4. PubMed ID: 17221871
[TBL] [Abstract][Full Text] [Related]
3. Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay.
Nogales-Gadea G; Rubio JC; Fernandez-Cadenas I; Garcia-Consuegra I; Lucia A; Cabello A; Garcia-Arumi E; Arenas J; Andreu AL; Martín MA
Hum Mutat; 2008 Feb; 29(2):277-83. PubMed ID: 17994553
[TBL] [Abstract][Full Text] [Related]
4. A novel PYGM mutation in a Korean patient with McArdle disease: the role of nonsense-mediated mRNA decay.
Sohn EH; Kim HS; Lee AY; Fukuda T; Sugie H; Kim DS
Neuromuscul Disord; 2008 Nov; 18(11):886-9. PubMed ID: 18667317
[TBL] [Abstract][Full Text] [Related]
5. [McArdle disease (gycogenosis type V): analysis of clinical, biological and genetic features of five French patients].
Delmont E; Sacconi S; Berge-Lefranc JL; Aquaron R; Butori C; Desnuelle C
Rev Neurol (Paris); 2008 Nov; 164(11):912-6. PubMed ID: 18808785
[TBL] [Abstract][Full Text] [Related]
6. Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.
Vissing J; Duno M; Schwartz M; Haller RG
Brain; 2009 Jun; 132(Pt 6):1545-52. PubMed ID: 19433441
[TBL] [Abstract][Full Text] [Related]
7. Two novel mutations in the myophosphorylase gene in a patient with McArdle disease.
Deschauer M; Hertel K; Zierz S
Muscle Nerve; 2003 Jan; 27(1):105-7. PubMed ID: 12508303
[TBL] [Abstract][Full Text] [Related]
8. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.
Nogales-Gadea G; Pinós T; Lucia A; Arenas J; Camara Y; Brull A; de Luna N; Martín MA; Garcia-Arumí E; Martí R; Andreu AL
Brain; 2012 Jul; 135(Pt 7):2048-57. PubMed ID: 22730558
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.
Aquaron R; Bergé-Lefranc JL; Pellissier JF; Montfort MF; Mayan M; Figarella-Branger D; Coquet M; Serratrice G; Pouget J
Neuromuscul Disord; 2007 Mar; 17(3):235-41. PubMed ID: 17324573
[TBL] [Abstract][Full Text] [Related]
10. A new rare mutation (691delCC/insAAA) in exon 17 of the PYGM gene causing McArdle disease.
Quintans B; Sanchez-Andrade A; Teijeira S; Fernandez-Hojas R; Rivas E; López MJ; Navarro C
Arch Neurol; 2004 Jul; 61(7):1108-10. PubMed ID: 15262743
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in the PYGM gene in a family with pseudo-dominant transmission of McArdle disease.
Isackson PJ; Tarnopolsky M; Vladutiu GD
Mol Genet Metab; 2005 Jul; 85(3):239-42. PubMed ID: 15979037
[TBL] [Abstract][Full Text] [Related]
12. Cell models for McArdle disease and aminoglycoside-induced read-through of a premature termination codon.
Birch KE; Quinlivan RM; Morris GE
Neuromuscul Disord; 2013 Jan; 23(1):43-51. PubMed ID: 22818872
[TBL] [Abstract][Full Text] [Related]
13. Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study.
Martín MA; Rubio JC; Buchbinder J; Fernández-Hojas R; del Hoyo P; Teijeira S; Gámez J; Navarro C; Fernández JM; Cabello A; Campos Y; Cervera C; Culebras JM; Andreu AL; Fletterick R; Arenas J
Ann Neurol; 2001 Nov; 50(5):574-81. PubMed ID: 11706962
[TBL] [Abstract][Full Text] [Related]
14. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
15. Two novel mutations and evidence for haploinsufficiency of the ADAR gene in dyschromatosis symmetrica hereditaria.
Liu Q; Jiang L; Liu WL; Kang XJ; Ao Y; Sun M; Luo Y; Song Y; Lo WH; Zhang X
Br J Dermatol; 2006 Apr; 154(4):636-42. PubMed ID: 16536805
[TBL] [Abstract][Full Text] [Related]
16. Six novel mutations in the myophosphorylase gene in patients with McArdle disease and a family with pseudo-dominant inheritance pattern.
Wu Y; Weber JL; Vladutiu GD; Tarnopolsky MA
Mol Genet Metab; 2011 Dec; 104(4):587-91. PubMed ID: 21880526
[TBL] [Abstract][Full Text] [Related]
17. PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
de Luna N; Brull A; Lucia A; Santalla A; Garatachea N; Martí R; Andreu AL; Pinós T
Neuromuscul Disord; 2014 Dec; 24(12):1079-86. PubMed ID: 25240406
[TBL] [Abstract][Full Text] [Related]
18. A novel nonsense mutation (R269X) in the myophosphorylase gene in a patient with McArdle disease.
Deschauer M; Opalka JR; Lindner A; Zierz S
Mol Genet Metab; 2001 Dec; 74(4):489-91. PubMed ID: 11749054
[TBL] [Abstract][Full Text] [Related]
19. Two novel mutations in the muscle glycogen phosphorylase gene in McArdle's disease.
Gámez J; Rubio JC; Martín MA; Fernández-Cadenas I; Garcia-Arumi E; Andreu AL; Arenas J
Muscle Nerve; 2003 Sep; 28(3):380-2. PubMed ID: 12929201
[TBL] [Abstract][Full Text] [Related]
20. Novel human pathological mutations. Gene symbol: PYGM. Disease: McArdle disease.
Garcia-Consuegra I; Rubio JC; Nogales-Gadea G; Bautista J; Jiménez S; Cabello A; Lucía A; Andreu AL; Arenas J; Martin MA
Hum Genet; 2009 Apr; 125(3):343. PubMed ID: 19320016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
